Table 1 Baseline information of patients.

From: Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway

Patients (number [n = 80])

Characters

Age (median [range])

58 (26–79)

Sex (number [rates])

Male (61 [76.25%])

Female (19 [23.75%])

ECOG status (number [rates])

0 (43 [53.75%])

1 (37 [46.25%])

MSKCC risk (number [rates])

Favorable (17 [21.25%])

Intermediate (35 [43.75%])

Poor (28 [35.00%])

Back to article page